An ex-employee of hospital group Circle BMI described its former fertility asset as “a nice little profitable part of the business”. And yet all the UK hospital groups are selling them off. Why?
Italian industrialists have a penchant for investing in health care services. And it is striking how many of the major groups in Italy are controlled by wealthy families.
At a session on ESG at HBI 2023 ('Building a robust ESG framework') all panellists appeared to be on board with the idea that adopting serious ESG strategies is not only good for society and the planet, it's also ultimately good for the business itself and its shareholders. Companies need to shift from thinking of it as a burdensome cost to thinking of it as a necessary investment. Is this true?
In March, the World Health Organisation published an updated list of 55 countries that have reached a critical point when it comes to shortages in their health care workforces. The implication - or ‘recommendation’ - is that wealthier western nations in particular need to cool it when it comes to actively recruiting nurses and doctors from selected countries.
From silicon valley to national legislatures, debates around the impact artificial intelligence could have on the future of humanity seem to have reached a new fever pitch in recent weeks.
When German health minister Karl Lauterbach proposed his hospital reforms, he probably imagined himself as the hero of the drama, striding across the political stage and heroically redefining an oversupplied market. Instead, increasingly he looks to have penned a farce.
This week the BBC released a panorama episode entitled ‘Private ADHD Clinics Exposed’, in which it went undercover to find that three private clinics in the UK are giving out ADHD prescriptions based on a short and potentially unreliable online assessment delivered by a non-psychiatrist. Is there a wider issue that there is a perverse incentive in private health care to over diagnose and over prescribe?
When an organisation is marred by a reputational scandal so harmful that it jeopardises the bottom line, often a corporate rebrand is the only solution. This course of action is nothing new and there are countless examples of successful makeovers across industries, and health care is no different.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
